Covestor’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Covestor's GILD Position: Q1 2026 in Review
Covestor reduced its Gilead Sciences (GILD) stake by 24% in Q1 2026, selling an estimated $47.9K and leaving 1,057 shares worth $147K. The position accounts for 0.1% of the portfolio, ranked #155.
Covestor first reported a position in GILD in Q4 2021 and has held it in 18 quarters since. The position peaked at $336K in Q2 2024. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Covestor held 1,057 shares of Gilead Sciences worth $147K as of Q1 2026.
- Covestor sold 342 Gilead Sciences shares in Q1 2026, an estimated $47.9K.
- Gilead Sciences made up 0.1% of Covestor's portfolio in Q1 2026, its #155 holding.
- Covestor first reported a position in Gilead Sciences in Q4 2021 and has held it in 18 quarters since.
- Covestor's Gilead Sciences position peaked at $336K in Q2 2024.
- 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.